All lobbying filings
TODD STRATEGY GROUP
Lobbying for BRIDGEBIO PHARMA · Biopharmaceutical manufacturer.
Filing
2nd Quarter - Termination
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Oct 11, 2025
Income
$20,000.00
What the client paid this registrant for the period.
Client based in
California
Representation ended
Jun 30, 2025
The registrant reported terminating its work for this client.
Lobbyists on this filing
4
-
KATHERINE FLEMING COTTONPreviously held: Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
-
PAUL EDATTELPreviously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
-
DANIEL M TODDPreviously held: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
-
NICHOLAS UEHLECKEPreviously held: Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
Government bodies contacted
3
Lobbying activity
1
PBM Policy Reform. Prior authorization. Utilization management.